CytomX Therapeutics, Inc 10-Q for FY2020 Q3
CytomX Therapeutics, Inc. (CTMX)
10-Q
2020-11-05
For: 2020-09-30
View Original
Added on
April 09, 2026
About this 10-Q
CytomX Therapeutics, Inc filed this 10-Q on November 5, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $17.79M
- up 66.1% from $10.71M a year earlier
- Net loss
- $14.71M
- compared with a net loss of $23.7M a year earlier